000 01341 a2200349 4500
005 20250512203346.0
264 0 _c19841219
008 198412s 0 0 eng d
022 _a0344-4325
024 7 _a10.1007/BF01893019
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPangburn, M K
245 0 0 _aThe alternative pathway of complement.
_h[electronic resource]
260 _bSpringer seminars in immunopathology
_c1984
300 _a163-92 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aComplement Activation
650 0 4 _aComplement C3-C5 Convertases
_xmetabolism
650 0 4 _aComplement C3b
_xmetabolism
650 0 4 _aComplement C3b Inactivator Proteins
_xmetabolism
650 0 4 _aComplement Factor H
650 0 4 _aComplement Factor I
650 0 4 _aComplement Pathway, Alternative
650 0 4 _aEndopeptidases
_xmetabolism
650 0 4 _aErythrocytes
_ximmunology
650 0 4 _aHemoglobinuria, Paroxysmal
_ximmunology
650 0 4 _aHumans
650 0 4 _aProperdin
_xmetabolism
700 1 _aMüller-Eberhard, H J
773 0 _tSpringer seminars in immunopathology
_gvol. 7
_gno. 2-3
_gp. 163-92
856 4 0 _uhttps://doi.org/10.1007/BF01893019
_zAvailable from publisher's website
999 _c6238419
_d6238419